Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.

The genes glutathione S-transferase M1 (GSTM1) (chromosome 1p13.3) and glutathione S-transferase T1 (GSTT1) (22q11.2) code for cytosolic enzymes glutathione S-transferase (GST)-mu and GST-theta, respectively, which are involved in phase 2 metabolism. Both genes may be deleted. There is geographic and ethnic variation in genotype frequencies for both genes. In developed countries, colorectal cancer is the second most common cancer. Colorectal cancer has been inconsistently associated with polycyclic aromatic hydrocarbons in diet and tobacco. Because GST enzymes are involved in polycyclic aromatic hydrocarbon metabolism, it has been postulated that genotype may modify colorectal cancer risk associated with polycyclic aromatic hydrocarbon exposure. No consistent associations between GSTM1 or GSTT1 genotype and colorectal cancer have been observed. However, most studies have methodological limitations. Few have investigated gene-environment interactions. No interactions between GSTM1 or GSTT1 genotype and smoking and colorectal cancer risk have been reported. One polyp study suggests an interaction between GSTM1 genotype and smoking. Two studies suggest increased disease risk in subjects with high meat intake and GST nonnull genotype, contrary to the underlying hypothesis. One study suggests a strong inverse relation between colorectal adenomas and broccoli consumption, particularly in subjects who are GSTM1 null. These finding require confirmation. Methods for determining GSTM1 and GSTT1 genotype are well established. Population testing is not currently justified.

[1]  J. Witte,et al.  Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[2]  T. Rushmore,et al.  Glutathione S-transferases, structure, regulation, and therapeutic implications. , 1993, The Journal of biological chemistry.

[3]  K. Golka,et al.  Comparative genotyping and phenotyping of glutathione S-transferase GSTT1 , 1996, Archives of Toxicology.

[4]  D. S. St. John,et al.  Cancer Risk in Relatives of Patients with Common Colorectal Cancer , 1993, Annals of Internal Medicine.

[5]  S. London,et al.  Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. , 1995, Journal of the National Cancer Institute.

[6]  D. Christiani,et al.  Glutathione S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  C. Masimirembwa,et al.  Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A. , 1997, Clinica chimica acta; international journal of clinical chemistry.

[8]  S. Garte The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. , 1998, Carcinogenesis.

[9]  M. Pratt,et al.  Physical activity and health , 1996, BMJ.

[10]  J. Bruner,et al.  Genetic polymorphisms in glutathione S-transferase mu and theta, N-acetyltransferase, and CYP1A1 and risk of gliomas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  M. Warholm,et al.  Genotypic and phenotypic determination of polymorphic glutathione transferase T1 in a Swedish population. , 1995, Pharmacogenetics.

[12]  G. Coetzee,et al.  Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  M. Leppert,et al.  NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  J. Olsen,et al.  Genotype and phenotype of glutathione S-transferase mu in testicular cancer patients. , 1997, Pharmacogenetics.

[15]  P. Shields,et al.  Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients: An age and gender matched case–control study , 1996, Cancer.

[16]  Jack A. Taylor,et al.  Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. , 1993, Journal of the National Cancer Institute.

[17]  Jacques Ferlay,et al.  Cancer incidence in five continents. , 1976, IARC scientific publications.

[18]  H Vainio,et al.  The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. , 1993, Carcinogenesis.

[19]  Abelardo Avila-Curiel,et al.  Food, nutrition and the prevention of cancer: a global perspective , 1998 .

[20]  P. Knekt,et al.  Smoking and risk of colorectal cancer. , 1998, British Journal of Cancer.

[21]  N. Weiss,et al.  The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. , 1993, Cancer research.

[22]  D. Bell,et al.  Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. , 1996, Carcinogenesis.

[23]  E. Lee,et al.  Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. , 1998, The Journal of toxicological sciences.

[24]  A. Fryer,et al.  Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. , 1995, The Biochemical journal.

[25]  A. Rannug,et al.  Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. , 1994, Carcinogenesis.

[26]  K. Hemminki,et al.  Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. , 1994, Carcinogenesis.

[27]  D. Bell,et al.  Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. , 1998, Journal of the National Cancer Institute.

[28]  P. Dayer,et al.  Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers. , 1997, Pharmacogenetics.

[29]  J. Lear,et al.  Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. , 1996, British Journal of Cancer.

[30]  M. Schiffman,et al.  Re: "Fried foods and the risk of colon cancer". , 1990, American journal of epidemiology.

[31]  J. Högberg,et al.  Polymorphic distribution of glutathione transferase activity with methyl chloride in human blood. , 1994, Pharmacogenetics.

[32]  J. Manson,et al.  Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  J. Freudenheim,et al.  Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. , 1995, Cancer research.

[34]  G. Webb,et al.  Genetic heterogeneity of the human glutathione transferases: a complex of gene families. , 1990, Pharmacology & therapeutics.

[35]  N K Spurr,et al.  Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. , 1993, Carcinogenesis.

[36]  J. Ferlay,et al.  Estimates of the worldwide incidence of eighteen major cancers in 1985 , 1993, International journal of cancer.

[37]  J. Brockmöller,et al.  Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class mu gene detected by polymerase chain reaction. , 1992, Biochemical pharmacology.

[38]  A. Fryer,et al.  Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. , 1994, Carcinogenesis.

[39]  A. Fryer,et al.  Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[40]  M. Spitz,et al.  Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. , 1995, Carcinogenesis.

[41]  J. Little,et al.  The adenoma-carcinoma sequence and prospects for the prevention of colorectal neoplasia. , 1996, Critical reviews in oncogenesis.

[42]  K. Noda,et al.  Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. , 1994, Carcinogenesis.

[43]  L Nyström,et al.  Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. , 1996, Journal of the National Cancer Institute.

[44]  G. Steineck,et al.  Meat, cooking methods and colorectal cancer: A case‐referent study in Stockholm , 1991, International journal of cancer.

[45]  S. Z. Abdel‐Rahman,et al.  A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. , 1996, Cancer letters.

[46]  R. Clayton,et al.  The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. , 1993, Carcinogenesis.

[47]  J. Lear,et al.  Polymorphism at the glutathione S-transferase locus GSTM3: interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. , 1996, Cancer research.

[48]  H. Bolt,et al.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.

[49]  B. Mannervik,et al.  Glutathione transferase activity and isoenzyme composition in primary human breast cancers. , 1990, Cancer research.

[50]  H. Okkels,et al.  Glutathione S-transferase mu as a risk factor in bladder tumours. , 1996, Pharmacogenetics.

[51]  D. Bell,et al.  Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. , 1996, Carcinogenesis.

[52]  J. Lyon,et al.  Fried foods and the risk of colon cancer. , 1988, American journal of epidemiology.

[53]  R. Hayes,et al.  The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  A. Hirvonen Genetic Factors in Individual Responses to Environmental Exposures , 1995, Journal of occupational and environmental medicine.

[55]  J. Y. Park,et al.  CYP1A1 and GSTM1 polymorphisms and oral cancer risk. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  C. Bloomfield,et al.  Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect , 1996, The Lancet.

[57]  P. Couzigou,et al.  Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms , 1997, Human Genetics.

[58]  M. Relling,et al.  Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. , 1996, Pharmacogenetics.

[59]  K. Kelsey,et al.  Population-based study of glutathione S-transferase mu gene deletion in adult glioma cases and controls. , 1997, Carcinogenesis.

[60]  R. Strange,et al.  Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours , 1994, The Lancet.

[61]  E. Wynder,et al.  The consumption of well-done red meat and the risk of colorectal cancer. , 1994, American journal of public health.

[62]  The World Health Report 1997--conquering suffering, enriching humanity. , 1997, World health forum.

[63]  R. Doll,et al.  Trends in cancer incidence and mortality , 1994 .

[64]  E. Lee,et al.  Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and Malays. , 1995, Pharmacogenetics.

[65]  W. Willett,et al.  A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. , 1994, Journal of the National Cancer Institute.

[66]  M. Esteller,et al.  Susceptibility to endometrial cancer: influence of allelism at p53, glutathione S-transferase (GSTM1 and GSTT1) and cytochrome P-450 (CYP1A1) loci. , 1997, British Journal of Cancer.

[67]  N. Weiss,et al.  Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[68]  J. Hayes,et al.  Allelism at the glutathione S-transferase GSTM3 locus: interactions with GSTM1 and GSTT1 as risk factors for astrocytoma. , 1996, Carcinogenesis.

[69]  E. Lee,et al.  Glutathione S transferase-theta (GSTT1) genetic polymorphism among Chinese, Malays and Indians in Singapore. , 1995, Pharmacogenetics.

[70]  K. Nakachi,et al.  Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. , 1993, Cancer research.

[71]  G A Colditz,et al.  A prospective study of family history and the risk of colorectal cancer. , 1994, The New England journal of medicine.

[72]  W. Farrell,et al.  Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression. , 1996, British Journal of Cancer.

[73]  T. Rebbeck Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[74]  Henry J. Lin,et al.  Glutathione transferase (GSTM1) null genotype, smoking, and prevalence of colorectal adenomas. , 1995, Cancer research.

[75]  L. Marchand,et al.  CYP1A1 genetic polymorphisms and in situ colorectal cancer. , 1994, Cancer research.

[76]  W. Pearson,et al.  Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. , 1993, BMJ.

[77]  M. Leppert,et al.  Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[78]  K. Kelsey,et al.  Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[79]  E. Rimm,et al.  A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. , 1994, Journal of the National Cancer Institute.

[80]  V. Álvarez,et al.  Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer. , 1998, Journal of clinical pathology.

[81]  C. Wolf,et al.  Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. , 1991, Carcinogenesis.

[82]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[83]  W. Pearson,et al.  Use of site-directed mutagenesis of allele-specific PCR primers to identify the GSTM1 A, GSTM1 B, GSTM1 A,B and GSTM1 null polymorphisms at the glutathione S-transferase, GSTM1 locus. , 1993, The Biochemical journal.

[84]  C. J. Chen,et al.  Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. , 1995, Gastroenterology.

[85]  C. Matthias,et al.  Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. , 1996, American journal of surgery.

[86]  J. Broome,et al.  Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450 (CYP2D6) loci. , 1995, Cancer research.

[87]  K. Noda,et al.  Increased risk of lung cancer in Japanese smokers with class mu glutathione S-transferase gene deficiency. , 1993, Cancer letters.

[88]  D. Hunter,et al.  Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[89]  K. Comstock,et al.  GST1 gene deletion determined by polymerase chain reaction. , 1990, Nucleic acids research.

[90]  D. Bernstein,et al.  Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. , 1994, Carcinogenesis.

[91]  A. Mikelsaar,et al.  Human glutathione S-transferase GSTM1 genetic polymorphism in Estonia. , 1994, Human heredity.

[92]  N E Day,et al.  The design of case-control studies: the influence of confounding and interaction effects. , 1984, International journal of epidemiology.

[93]  C. Maugard,et al.  Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility. , 1998, Chemico-biological interactions.

[94]  S. Z. Abdel‐Rahman,et al.  Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. , 1996, Carcinogenesis.

[95]  C. Masimirembwa,et al.  Genetic polymorphism of cytochrome P4501A1, microsomal epoxide hydrolase, and glutathione S-transferases M1 and T1 in Zimbabweans and Venda of southern Africa. , 1998, Pharmacogenetics.

[96]  J. Rueff,et al.  Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population. , 1996, Teratogenesis, carcinogenesis, and mutagenesis.

[97]  M. Yano,et al.  CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous‐cell carcinoma of the esophagus , 1997, International journal of cancer.

[98]  M. Spitz,et al.  Glutathione s-transferase genotypes as risk factors for head and neck cancer. , 1995, American journal of surgery.

[99]  T. Reckwitz,et al.  Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder , 1996, Archives of Toxicology.

[100]  J. Somberg Genetic polymorphisms. , 2002, American journal of therapeutics.

[101]  J. Mclaughlin,et al.  Increased risk of colorectal cancer among smokers: Results of a 26‐year follow‐up of us veterans and a review , 1994, International journal of cancer.

[102]  E. Lee,et al.  Frequency of mutant CYPIA1, NAT2 and GSTM1 alleles in a normal Chinese population. , 1994, Pharmacogenetics.

[103]  J. Brockmöller,et al.  Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. , 1996, Cancer research.

[104]  T. Kawano,et al.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. , 1997, Journal of clinical gastroenterology.

[105]  A. Santamaria,et al.  Rapid detection of inducers of enzymes that protect against carcinogens. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[106]  I. Roberts-Thomson,et al.  Metabolic genotypes and risk for colorectal cancer , 2001, Journal of gastroenterology and hepatology.

[107]  K. Buetow,et al.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[108]  N. Roodi,et al.  Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. , 1998, Cancer research.

[109]  L. Rhodes IARC Handbook of Cancer Prevention Sunscreens, vol. 5. , 2001 .